Directed by N.M.K. Ng Ying Kin, PhD, the laboratory measures putative biological markers for various psychiatric conditions and treatment-resistance to usual medications.

Ng Ying Kin uses neurochemical analyses to identify peripheral biological markers for various psychiatric disorders.

Economic analyses Eric Latimer A cost analysis was performed to evaluate the impact of the HF programs, considering all costs incurred by participants. On average, the intervention cost $22,482 per person per year for high need participants

Many organizations, public institutions and bodies from a wide range of sectors take an active part in our program and keep an eye on our work with interest. The common projects we share with these partners aim to: Strengthen the bonds through

What is mental health recovery?

The goal of this study  is to understand how we can slow or reverse the emergence of AD symptoms

McGill and the Douglas have joined hands to create the StoP-AD Centre dedicated to the prevention of AD.

Alzheimer's disease: A ticking bomb Canada and the world face a ruinous increase in the incidence of dementia caused by Alzheimer’s disease (AD). Around the globe, more than 35 million people have dementia. Their care costs $600 billion each ye

Most anxiety disorders are treated with cognitive-behavioral therapy (CBT), medication, or a combination of the two.

Martin Lepage's team is working on the following neurocognitive and neuroimaging research projects.